Results 31 to 40 of about 459,821 (133)

Genotype-specific molecular and functional trajectories in NGLY1 deficiency: a comparative multi-omics study of patient-derived iPSC neurons [PDF]

open access: yesFrontiers in Cell and Developmental Biology
BackgroundNGLY1 deficiency is an ultra-rare congenital disorder of deglycosylation with prominent neurodevelopmental impairment and marked allelic heterogeneity.
Soukaina Amniouel   +5 more
doaj   +2 more sources

Orthopaedic phenotyping of NGLY1 deficiency using an international, family-led disease registry [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2019
Background NGLY1 deficiency is a rare autosomal recessive disorder caused by loss in enzymatic function of NGLY1, a peptide N-glycanase that has been shown to play a role in endoplasmic reticulum associated degradation (ERAD).
Eli M. Cahan, Steven L. Frick
doaj   +2 more sources

Transiently elevated plasma methionine, S‐adenosylmethionine and S‐adenosylhomocysteine: Unreported laboratory findings in a patient with NGLY1 deficiency, a congenital disorder of deglycosylation [PDF]

open access: yesJIMD Reports, 2019
We report on a 5‐year‐old female born to consanguineous parents, ascertained at the age of 23 months for an elevated plasma methionine level, a mildly abnormal total plasma homocysteine (tHcy), and elevated aminotransferases. She had global developmental
Caitlin A. Chang   +4 more
doaj   +2 more sources

NGLY1 deficiency: a prospective natural history study. [PDF]

open access: yesHum Mol Genet, 2023
Abstract N-glycanase 1 (NGLY1) deficiency is a debilitating, ultra-rare autosomal recessive disorder caused by loss of function of NGLY1, a cytosolic enzyme that deglycosylates other proteins. It is characterized by severe global developmental delay and/or intellectual disability, hyperkinetic movement disorder, transient elevation of
Tong S   +10 more
europepmc   +3 more sources

Comparative proteomics of HepG2 cells reveals NGLY1 as an important regulator of ferroptosis resistance and iron uptake. [PDF]

open access: yesPLoS ONE
NGLY1 deficiency is a rare genetic disorder caused by mutations in the NGLY1 gene. This disorder presents a wide range of clinical symptoms, and its severity varies among affected individuals.
Stuart Emmerson   +6 more
doaj   +2 more sources

Drug screens of NGLY1 deficiency in worm and fly models reveal catecholamine, NRF2 and anti-inflammatory-pathway activation as potential clinical approaches [PDF]

open access: yesDisease Models & Mechanisms, 2019
N-glycanase 1 (NGLY1) deficiency is an ultra-rare and complex monogenic glycosylation disorder that affects fewer than 40 patients globally. NGLY1 deficiency has been studied in model organisms such as yeast, worms, flies and mice.
Sangeetha Iyer   +8 more
doaj   +2 more sources

Expanding the clinical and molecular spectrum of NGLY1 deficiency: A multicenter cohort

open access: yesMolecular Genetics and Metabolism
NGLY1 deficiency is an ultra-rare multisystem disorder characterized by developmental delay, hyperkinetic movement disorder, hypo-/alacrimia, peripheral neuropathy, and elevated transaminases.We conducted a multicenter retrospective study including 15 patients from 11 families to evaluate the clinical, biochemical, and molecular features of the disease.
Öztürk-Hişmi, Burcu   +19 more
openaire   +5 more sources

JF1/B6F1 Ngly1-/- mouse as an isogenic animal model of NGLY1 deficiency. [PDF]

open access: yesProc Jpn Acad Ser B Phys Biol Sci, 2021
N-Glycanase 1 (NGLY1) deficiency is a congenital disorder caused by mutations in the NGLY1 gene. Because systemic Ngly1-/- mice with a C57BL/6 (B6) background are embryonically lethal, studies on the mechanism of NGLY1 deficiency using mice have been problematic.
Asahina M   +6 more
europepmc   +4 more sources

The STING pathway drives noninflammatory neurodegeneration in NGLY1 deficiency. [PDF]

open access: yesJ Exp Med
The STING pathway is increasingly recognized as a key regulator of neuroinflammation in neurodegenerative disease, but its role in noninflammatory conditions remains unclear. We generated a postnatal inducible whole-body Ngly1 knockout mouse (iNgly1−/−) to model NGLY1 deficiency, an early-onset neurodegenerative disorder.
Yang K   +15 more
europepmc   +3 more sources

Assay for the peptide:N-glycanase/NGLY1 and disease-specific biomarkers for diagnosing NGLY1 deficiency [PDF]

open access: yesThe Journal of Biochemistry, 2021
Abstract Cytosolic peptide:N-glycanase (NGLY1 in mammals), a highly conserved enzyme in eukaryotes, catalyses the deglycosylation of N-glycans that are attached to glycopeptide/glycoproteins. In 2012, an autosomal recessive disorder related to the NGLY1 gene, which was referred to as NGLY1 deficiency, was reported.
Hirayama, Hiroto, Suzuki, Tadashi
openaire   +3 more sources

Home - About - Disclaimer - Privacy